Cargando…
Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now spread across the globe. As part of the worldwide response, many molecular diagnostic platforms have been granted emergency use authorization (EUA) by the Food and Drug Administration (FDA) to identify SARS-CoV-2 positive patients....
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society for Microbiology
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383520/ https://www.ncbi.nlm.nih.gov/pubmed/32332061 http://dx.doi.org/10.1128/JCM.00783-20 |